Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
MD Anderson Cancer Center
May 28, 2024, 14:06 |
Insight
Myeloma Paper of the Day, May 28th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Retrospective Memorial Sloan Kettering study suggests…
May 28, 2024, 12:19 |
Opinion
Patrick Hwu: Pioneering new ideas or changing the status quo often comes with a price
Patrick Hwu shared a post on LinkedIn: "Pioneering new ideas or changing the status quo…
May 28, 2024, 09:06 |
Blog
Eric K. Singhi: Emerging TKIs in the HER2 space at ASCO
Eric K. Singhi shared the following on X: ''Beamion LUNG-1: Zongertinib in patients with HER2 aberration…
May 27, 2024, 07:37 |
Blog
Eric K. Singhi on BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo in 1L ES-SCLC
Eric K. Singhi shared the following on X: “BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo…
May 27, 2024, 05:56 |
Blog
Pavlos Msaouel: Grateful to know and follow Jad Chahoud
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a post…
May 27, 2024, 05:00 |
Blog
Eric K. Singhi: Don’t miss out on IASLC representation at the ASCO Plenary
Eric K. Singhi shared on X: ,…
May 26, 2024, 15:26 |
Blog
Sendurai Mani: Celebration of my paper reaching over 10,000 citations
Sendurai Mani shared a post on LinkedIn: ''I am deeply grateful to the incredible members…
May 26, 2024, 06:31 |
Insight
Vivek Subbiah: Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma
Vivek Subbiah shared a post on X/Twitter: "Impressive response to dabrafenib, trametinib, and osimertinib in a…
May 26, 2024, 04:10 |
Blog
Jason A. Mouabbi: Honored to chair and present at the ABC2024 session on ILC
Jason A. Mouabbi, Assistant Professor at The University of Texas MD Anderson Cancer Center, shared…
May 25, 2024, 12:41 |
Insight
Vivek Subbiah: KRAS inhibitors are here to stay
Vivek Subbiah shared on X: “KRAS inhibitors are here ASCO24 & here to stay for all…
93
94
95
96
97
All:
1445
Posts:
941 - 950
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube